Speaker Profile

Ph.D., CEO, Strata Oncology

Dr. Rhodes is co-founder and CEO of Strata Oncology. He was co-founder and CEO of a successful cancer genomics and informatics company, Compendia Bioscience, which was acquired by Life Technologies, now a part of Thermo Fisher Scientific. He was subsequently Head of Oncology Strategy, leading the Compendia business unit for Thermo Fisher. He also serves as Adjunct Assistant Research Professor in the Department of Pathology at the University of Michigan Medical School. Dr. Rhodes received both a Bachelor of Science in Molecular Biology and a Doctorate in Bioinformatics and Cancer Biology from The University of Michigan, Ann Arbor.


Systematizing Precision Oncology Across a Large Network of Healthcare Systems and Biopharmas
Rapid and efficient identification of all eligible patients across a healthcare system, along with broad access to tumor molecular profiling, is a vital component to the successful completion of precision oncology trials. This talk will cover the requirements to streamline precision oncology across a network of healthcare systems and pharma companies, and the paths to deliver precision oncology at scale.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.